Mirum Pharmaceuticals (MIRM) logo

MIRM earnings date, and what happened the last 4 times

Next report

Wed Nov 4

Quality Score today 0

After the close, in 9 days. Expected: the company has not confirmed it.

MIRM closed higher after 0 of its last 4 reports. On average it closed -8.5% the session after a report.

The moment MIRM reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when MIRM reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after MIRM's last 4 reports

MIRM's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 5, 20262026 · After close3estimated-14.7%-11.0%
May 6, 20262026 · After close14estimated0.0%-6.5%
Feb 25, 20262026 · After close19estimated-11.1%-15.1%
Nov 4, 20252025 · After close12estimated+3.5%-1.2%
  • Aug 5, 2026, after the close: the next session MIRM opened -14.7% and closed -11.0%, and five sessions on it stood -6.5%. Its Quality Score going in was 3 (Below Average), estimated.
  • May 6, 2026, after the close: the next session MIRM opened 0.0% and closed -6.5%, and five sessions on it stood -0.8%. Its Quality Score going in was 14 (Above Average), estimated.
  • Feb 25, 2026, after the close: the next session MIRM opened -11.1% and closed -15.1%, and five sessions on it stood -14.3%. Its Quality Score going in was 19 (Excellent), estimated.
  • Nov 4, 2025, after the close: the next session MIRM opened +3.5% and closed -1.2%, and five sessions on it stood +0.5%. Its Quality Score going in was 12 (Above Average), estimated.

Across these 4 reports MIRM opened higher after 1 of 4 and closed higher after 0 of 4; on average it opened -5.6%, closed -8.5%, and stood -5.3% five sessions on. Its Quality Score is 0 today, against 3 going into its Aug 5, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -15.1% after the Feb 25, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see MIRM's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about MIRM's earnings

As of Oct 26, 2026: Mirum Pharmaceuticals (MIRM): expected to report Wed Nov 4, after the close. MIRM closed higher after 0 of its last 4 reports. Its Quality Score is 0 (Below Average). Scores as of 10:16 PM ET, 15 minutes behind.

When is MIRM's next earnings date?

Expected to report Wed Nov 4, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. MIRM closed higher after 0 of its last 4 reports. Past behavior, not a forecast.

Does MIRM report before or after the market?

MIRM is expected to report Wed Nov 4, after the close. Its last 4 reports came after the close.

How did MIRM stock react to its last earnings report?

Aug 5, 2026, after the close: the next session MIRM opened -14.7% and closed -11.0%, and five sessions on it stood -6.5%.

Does MIRM stock usually go up after earnings?

MIRM closed higher after 0 of its last 4 reports. On average it closed -8.5% the session after a report, after opening -5.6%. Past behavior, not a forecast.

Mirum Pharmaceuticals' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.